Environment-responsive drug delivery systems for targeted cancer therapy

doi:10.5246/jcps.2015.01.001

Journal of Chinese Pharmaceutical Sciences ›› 2015, Vol. 24 ›› Issue (1): 1-11.DOI: 10.5246/jcps.2015.01.001

• Review • Next Articles

Environment-responsive drug delivery systems for targeted cancer therapy

Chunmei Peng, Jie Shen, Weiyue Lu^*

Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education, Department of Pharmaceutics, and School of Pharmacy, Fudan University, Shanghai 201203, China

Received:2014-07-08 Revised:2014-07-24 Online:2015-01-15 Published:2014-07-28
Contact: Tel.: 86-13916210734
About author:Weiyue Lu, Ph.D. is a Professor of pharmaceutics, School of Pharmacy at Fudan University. Professor Lu obtained his B.S. degree in Medicinal Chemistry from Department of Pharmacy, Shanghai First Medical College (Now School of Pharmacy, Fudan University) in 1982, and his Ph.D. degree in pharmaceutics from Shanghai Institute of Pharmaceutical Industry. He also serves as the director of Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education, China, Associate Director of the Pharmaceutics Committee of Chinese Pharmaceutical Association (CPA), Director of the Pharmaceutics Committee of Shanghai Pharmaceutical Association, Council member of Chinese Pharmaceutical Industry Research and Developmen Association and also a member of standing committee, Nano-oncology Committee of Chinese Anti-cancer Association, associate chief editor for Pharmaceutical volume in Pharmaceutical Science Part of Encyclopendia of Chinese Medicine, member of Editorial Board for Drug Delivery and Translational Research, Asian Journal of Pharmaceutical Sciences, Acta Pharmaceutica Sinica, Chinese Journal of Pharmaceuticals, Journal of Chinese Pharmaceutical Sciences. Professor Lu’s research focuses on brain, lymphatic system and its tumor targeting strategy and drug delivery system. Since 2000, he has published 80 peer-reviewed papers and holds 20 patents. He has received the National 100 Excellent Doctoral Dissertation Award (Advisor) in 2012 and 2013. At present, he has host a project on the National Basic Research Program (973) in 2013. He has ever won Shanghai YuCai Award, “Prize for Excellent Teacher” funded by Baosteel Fellowship, Gold Medal of “Xu Guang Qi Science and Technology Medal” and the second prize of scientific and technological progress award of Chinese Pharmaceutical Association.
Supported by:
National Basic Research Program of China (Grant No. 973 Program, 2013CB932500), National Natural Science Foundation of China (Grant No. 81273458) and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20110071130011).

Abstract

Abstract:

In order to deliver and/or release anti-cancer therapeutics at the tumor sites, novel environment-responsive drug deliverysystems are designed to specifically respond to tumor microenvironment (such as low pH and hypoxia). Due to their extraordinary advantages, these environment-responsive drug delivery systems can improve antitumor efficacy, and most importantly, they can decrease toxicity associated with the anti-cancer therapeutics. This review highlights different mechanisms of environment-responsive drug delivery systems and their applications for targeted cancer therapy.

Key words: Cancer, Environment-responsive, Target, Smart drug delivery systems

CLC Number:

R965

Supporting:

Chunmei Peng, Jie Shen, Weiyue Lu. Environment-responsive drug delivery systems for targeted cancer therapy[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(1): 1-11.

References

[1] Van Meerbeeck, J.P.; Scherpereel, A.; Surmont ,V.F.; Baas, P. Crit. Rev. Oncol. Hematol . 2011, 78, 92-111.

[2] Kim, J.H.; Kim, H.S.; Kwon, J.H.; Park, S.; Kim, H,Y.; Jung, J.Y. Lung Cancer. 2009, 63, 405-409.

[3] Islam, T.; Josephson, L. Cancer Biomark. 2009, 5, 99-107.

[4] Das, M.; Mohanty, C.; Sahoo, S.K. Expert Opin. Drug Deliv. 2009, 6, 285-304.

[5] Sun, Y.; Wang, C. Acta Pharm. Sin. 2008, 43, 992-996.

[6] Ojugo, A.S.; McSheehy, P.M.; McIntyre, D.J.; McCoy, C.; Stubbs, M.; Leach, M.O. NMR Biomed. 1999, 12, 495-504.

[7] Stubbs, M.; McSheehy, P.M.; Griffiths, J.R.; Bashford, C.L. Mol. Med. Today. 2000, 6, 15-19.

[8] Lee, R.J.; Wang, S.; Low, P.S. Biochim. Biophys Acta. 1996, 1312, 237-242.

[9] Leriche, G.; Chisholm, L.; Wagner, A. Bioorg. Med. Chem. 2012, 20, 571-582.

[10] Jiang, S.; Yao, Y.; Nie, Y.; Yang, J.; Yang, J. J. Colloid Interface Sci. 2011, 364, 264-271.

[11] Alani, A.W.; Bae, Y.; Rao, D.A.; Kwon, G.S. Biomaterials. 2010, 31, 1765-1772.

[12] Zhao, B.X.; Zhao, Y.; Huang, Y.; Luo, L.M.; Song, P.; Wang, X. Biomaterials. 2012, 33, 2508-2520.

[13] Wang, C.H.; Wang, C.H.; Hsiue, G.H. J. Control. Release. 2005, 108, 140-149.

[14] Gao, G.H.; Lee, J.W.; Nguyen, M.K.; Im, G.H.; Yang, J.; Heo, H. J. Control. Release. 2011, 155, 11-17.

[15] Oh, K.T.; Kim, D.; You, H.H.; Ahn, Y.S.; Lee, E.S. Int. J. Pharm. 2009, 376, 134-140.

[16] Lu, C.; Xing, M.M.; Zhong, W. Nanomedicine. 2011, 7, 80-87.

[17] Wang, X.; Wu, G.; Lu, C.; Zhao, W.; Wang, Y.; Fan, Y. Eur. J. Pharm. Sci. 2012, 47, 256-264.

[18] Du, C.; Deng, D.; Shan, L.; Wan, S.; Cao, J.; Tian, J. Biomaterials. 2013, 34, 3087-3097.

[19] Tang, R.; Ji, W.; Panus, D.; Palumbo, R.N.; Wang, C. J. Control. Release. 2011, 151, 18-27.

[20] Hu, F.Q.; Zhang, Y.Y.; You, J.; Yuan, H.; Du, Y.Z. Mol. Pharm. 2012, 9, 2469-2478.

[21] Jin, Y.H.; Hu, H.Y.; Qiao, M.X.; Zhu, J.; Qi, J.W.; Hu, C.J. Colloids Surf. B Biointerfaces. 2012, 94, 184-191.

[22] Niu, J.; Su, Z.; Xiao, Y.; Huang, A.; Li, H.; Bao, X. Eur. J. Pharm. Sci. 2012, 45, 216-226.

[23] Goncalves, M.; Figueira, P.; Maciel, D.; Rodrigues, J.; Qu, X.; Liu, C. Acta Biomater. 2014, 10, 300-307.

[24] Ganta, S.; Devalapally, H.; Shahiwala, A.; Amiji, M. J. Control. Release. 2008, 126, 187-204.

[25] Song, N.; Liu, W.; Tu, Q.; Liu, R.; Zhang, Y.; Wang, J. Colloids Surf. B Biointerfaces. 2011, 87, 454-463.

[26] Koo, A.N.; Min, K.H.; Lee, H.J.; Lee, S.U.; Kim, K.; Kwon, I.C. Biomaterials. 2012, 33, 1489-1499.

[27] Manickam, D.S.; Li, J.; Putt, D.A.; Zhou, Q.H.; Wu, C.; Lash, L.H. J. Control. Release. 2010, 141, 77-84.

[28] He, Y.; Nie, Y.; Xie, L.; Song, H.; Gu, Z. Biomaterials. 2014, 35, 1657-1666.

[29] Brisson, L.; Reshkin, S.J.; Gore, J.; Roger, S. Eur. J. Cell Biol. 2012, 91, 847-860.

[30] Liang, L.; Lin, S.W.; Dai, W.; Lu, J.K.; Yang, T.Y.; Xiang, Y. J. Control Release. 2012, 160, 618-629.

[31] Zhu, L.; Perche, F.; Wang, T.; Torchilin, V.P. Biomaterials. 2014, 35, 4213-4122.

[32] Lee, G.Y.; Park, K.; Kim, S.Y.; Byun, Y. Eur. J. Pharm. Biopharm. 2007, 67, 646-654.

[33] Huang, S.; Shao, K.; Kuang, Y.; Liu, Y.; Li, J.; An, S. Biomaterials. 2013, 34, 5294-5302.

[34] Harada, S.; Ehara, S.; Ishii, K.; Sato, T.; Koka, M.; Kamiya, T. Nuclear Instruments & Methods in Physics Research Section B-Beam Interactions with Materials and Atoms. 2014, 318, 173-177.

[35] Hossann, M.; Wiggenhorn, M.; Schwerdt, A.; Wachholz, K.; Teichert, N.; Eibl, H. Biochim. Biophys. Acta. 2007, 1768, 2491-2499.

[36] Kim, M.S.; Lee, D.W.; Park, K.; Park, S.J.; Choi, E.J.; Park, E.S. Colloids Surf. B Biointerfaces. 2014, 116, 17-25.

[37] Lin, Z.Q.; Gao, W.; Hu, H.X.; Ma, K.; He, B.; Dai, W.B. J. Control. Release. 2014, 174, 161-170.

[38] Yoon, H.Y.; Saravanakumar, G.; Heo, R.; Choi, S.H.; Song, I.C.; Han, M.H. J. Control. Release. 2012, 160, 692-698.

[39] Tietze, R.; Lyer, S.; Durr, S.; Struffert, T.; Engelhorn, T.; Schwarz, M. Nanomedicine-Nanotechnol. Biol. Med. 2013, 9, 961-971.

[40] Fomina, N.; Sankaranarayanan, J.; Almutairi, A. Adv. Drug Deliv. Rev. 2012, 64, 1005-1020.

[41] Cho, Y.I.; Park, S.; Jeong, S.Y.; Yoo, H.S. Eur. J. Pharm. Biopharm. 2009, 73, 59-65.

[42] Yin, T.H.; Wang, P.; Li, J.G.; Zheng, R.Q.; Zheng, B.W.; Cheng, D. Biomaterials. 2013, 34, 4532-4543.

[43] Huang, S.; Shao, K.; Liu, Y.; Kuang, Y.; Li, J.; An, S. ACS Nano. 2013, 7, 2860-2871.

[44] Pradhan, P.; Giri, J.; Rieken, F.; Koch, C.; Mykhaylyk, O.; Doblinger, M. J. Control. Release. 2010, 142, 108-121.

[45] Wen, H.; Guo, J.; Chang, B.; Yang, W. Eur. J. Pharm. Biopharm. 2013, 84, 91-98.

[46] Yu, S.F.; Wu, G.L.; Gu, X.; Wang, J.J.; Wang, Y.N.; Gao, H. Colloids Surf. B Biointerfaces. 2013, 103, 15-22.

[47] Shi, J.J.; Liu, Y.; Wang, L.; Gao, J.; Zhang, J.; Yu, X.Y. Acta Biomaterialia. 2014, 10, 1280-1291.

[48] Qiao, Z.Y.; Zhang, R.; Du, F.S.; Liang, D.H.; Li, Z.C. J. Control. Release. 2011, 152, 57-66.

[49] Grull, H.; Langereis, S. J. Control. Release. 2012, 161, 317-327.

[50] Ranjan, A.; Jacobs, G.C.; Woods, D.L. J. Control. Release. 2012, 158, 487-494.

[51] de Smet, M.; Langereis, S.; van den Bosch, S.; Bitter, K.; Hijnen, N.M.; Heijman, E. J. Control. Release. 2013, 169, 82-90.

Environment-responsive drug delivery systems for targeted cancer therapy

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Mengyao Wu, Lu Liu, Peng Zhang, Lele Zhang, Yun Gong, Xiuwei Yang. Exploring the mechanism of Buxue Yimu Pills on postpartum abdominal pain through network pharmacology and experimental validation [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 691-703.
[2]	Gedi Zhang, Gengxin Liu, Ziyou Yan. Therapeutic efficacy evaluation and mechanism of action based on meta-analysis and network pharmacology of Li Chong Decoction (Bolus) for cancer treatment [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 720-735.
[3]	Haoxin Du, Qi Bao, Huangqianyu Li, Yichen Zhang, Haishaerjiang Wushouer, Luwen Shi, Xiaodong Guan. Health status of middle-aged and elderly cancer survivors in China [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 744-754.
[4]	Wen Lv, Ying Fu. Advances in immune-targeted therapy for Graves' ophthalmopathy [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(8): 616-625.
[5]	Huimin Wang, Yuying Zhao, Xiaoyan Xu, Humin Xie, Meiting Jiang, Hongda Wang, Bei Xu, Xiaohang Li, Simiao Wang, Boxue Chen, Feifei Yang, Wenzhi Yang. Steaming-induced conversion of the volatile components for P. ginseng, P. quinquefolius, and P. notoginseng by headspace sampling gas chromatography-mass spectrometry (HS-GC-MS) and untargeted metabolomics analysis [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(8): 645-664.
[6]	Wentao Zhu, Wanglong Hong, Miaomiao Zheng, Guoqiang Ma, Aizong Shen. Combination of pembrolizumab and chemotherapy as first-line treatment in advanced triple-negative breast cancer: a cost-effectiveness analysis [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 587-597.
[7]	Mengya Wang, Kuanyou Zhang, Xin Chen, Hao Fu, Shouchun Peng. Study on the mechanism of Rhinoceros Horn and Rehmannia Decoction in the treatment of systemic lupus erythematosus based on the method of network pharmacology [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(5): 351-359.
[8]	Guangzhi Shen, Xingang Cui, Zhimin Na, Yulong Zou, Guihua Zou. A network pharmacology approach to explore the pharmacological mechanism of Epimedium brevicornum in sexual dysfunction [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(5): 379-391.
[9]	Yancong Zhao, Huiyuan Gong, Jinghua Li. Overexpression of hBD3 inhibits cell proliferation, cell cycle, and migration in colon cancer cells [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(4): 250-259.
[10]	Ciyan Peng, Jing Chen, Sini Li, Jianhe Li, Liubao Peng. Evidence-based pharmacoeconomic evaluation of palbociclib in combination with letrozole versus docetaxel in combination with epirubicin in the first-line treatment of advanced breast cancer with epirubicin [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 214-222.
[11]	Yuqian Zhang, Haiying Niu, Yiran Jin. Network pharmacology-based strategy to investigate anticancer mechanisms of Catharanthus roseus (L.) G. Don [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 911-922.
[12]	Kai Li, Bingjie Tang, Xinlong Chai, Yang Ping, Lihong Wang, Jin Su. Sialic acid-functionalized targeted drug delivery systems: advances in tumor and inflammation therapy by binding to Siglecs or selectin receptors [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(10): 773-795.
[13]	Ning Ding, Tao Zhang, Ji Luo, Haochen Liu, Yu Deng, Yongheng He. Study on the mechanism of Baishao Qiwu Decoction in the treatment of colorectal cancer based on network pharmacology and molecular docking [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(1): 17-31.
[14]	Neha Dangi, Shikha Sharma. Cancer chemotherapy with novel bioactive natural products [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(8): 589-607.
[15]	Weiping Zhao, Qi Ge, Zijun Ding, Leizhi Pan, Ziqing Gu, Yang Liu, Hua Cai. Network pharmacology and metabolomics-based detection of the potential pharmacological effects of the active components in Chrysanthemum morifolium 'Chuju' [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(6): 412-428.